BCL2L11 and acute lymphoblastic leukemia: Although we were unable to generate deletion-containing lines of other lineages, we expect that introduction of the deletion, which phenocopies a BIM knockdown of BIM, will likely confer glucocorticoid resistance in other ALL cell lines [27], [31], [32].